Purchase Order HHSN2632005MD501703P

The National Institutes of Health, on behalf of the National Eye Institute, awarded Metabolon, Inc. a $1.7 million firm fixed price purchase order to conduct metabolomics research of approximately 2,001 serum samples from the Age-Related Eye Disease Study 2 clinical trial. Metabolon will identify over 1,000 metabolites in the samples, map them to biological pathways, and perform data processing, quality control, and preliminary statistical analysis to identify metabolites associated with...

This federal contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Joslin Diabetes Center, Inc. The contract is for the "Family Management of Childhood Diabetes (Type 1): Clinical Sites" and has a ceiling value of $4,515,780.39. The contract is a definitive contract with a cost-no-fee pricing type and was awarded on November 1, 2003, with an ultimate completion date of October 31, 2009. There was no set-aside used...

The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $227,655 firm fixed price purchase order to Children's Hospital, a division of Children's National Medical Center, to support the development and implementation of the "Young At Heart Type 2 Diabetes Research Longitudinal Protocol." Per the solicitation, this involves protocol development, research services, and participant recruitment for the joint NIDDK/Children's Hospital...

This $180,000.00 firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the U.S. Department of Health and Human Services, to Joslin Diabetes Center, Inc., a non-profit organization based in Boston, Massachusetts. The contract does not have a set-aside designation. The purpose of this award is to provide specialized research-related services and materials to support NIDDK's diabetes studies. Joslin...

This is a $1,135,259.18 cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Social & Scientific Systems, Inc., a for-profit subsidiary of DLH Holdings Corp. The order supports epidemiology services for the "DIABETES METABOLITES AND METABOLOMICS IN THE SISTER STUDY" under the "SUPPORT SERVICES FOR EPIDEMIOLOGY" program. No set-aside was used. Social & Scientific Systems has...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $2,805,430.26 Cost Plus Fixed Fee contract to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization, to perform non-clinical safety assessment of TTHX1114 to support a Fuchs Endothelial Corneal Dystrophy Investigational New Drug (IND) application. This contract was issued as a Delivery Order under the "CRO...

The Department of Health and Human Services' National Institutes of Health's National Human Genome Research Institute awarded a $986,250 firm fixed price purchase order to New York Stem Cell Foundation Inc. to provide beta cell differentiation and cell assay services. Under this two-year contract set to run from July 2020 through July 2022, New York Stem Cell Foundation will deliver products and services supporting the NIH's genomic research efforts, including differentiation of beta cells and...

The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $387,422 firm fixed price purchase order to the Regents of the University of Colorado Office of Contracts and Grants Division, doing business as the University of Colorado in Boulder. The contract calls for the prime contractor to perform state-of-the-art measurements in studies of diabetic kidney disease in type 1 and type 2 diabetes. Specifically, the contractor will provide...

This federal contract award, valued at $24,500.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to the prime contractor Ozgene PTY LTD, an Australian company that specializes in providing genetically modified mice and related services for biomedical research. The contract, which has a firm fixed price pricing type, is for services to study the generation of Dio2dre mouse embryonic stem (ES) cells. The contract has no set-aside designation and is...

This is a delivery order under contract HHSN275275201300023I/HHSN275000011 awarded by the National Institutes of Health (NIH) National Institute of Child Health and Human Development to the Regents of the University of Minnesota, Office of Sponsored Projects Administration. The order, valued at $1,073,995.69, is for the "Genetic Factors in Birth Defects-Genomic Testing" program, which involves research, testing, and other services related to genetic factors contributing to birth...